These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15157763)

  • 1. A Leishmania donovani gene that confers accelerated recovery from stationary phase growth arrest.
    Hoyer C; Zander D; Fleischer S; Schilhabel M; Kroener M; Platzer M; Clos J
    Int J Parasitol; 2004 Jun; 34(7):803-11. PubMed ID: 15157763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leishmania: overexpression and comparative structural analysis of the stage-regulated meta 1 gene.
    Uliana SR; Goyal N; Freymüller E; Smith DF
    Exp Parasitol; 1999 Jul; 92(3):183-91. PubMed ID: 10403759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo selection for Leishmania donovani miniexon genes that increase virulence in Leishmania major.
    Zhang WW; Matlashewski G
    Mol Microbiol; 2004 Nov; 54(4):1051-62. PubMed ID: 15522086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of guanylyl cyclase by intracellular Ca2+ in relation to the infectivity of the protozoan parasite, Leishmania donovani.
    Karmakar S; Ukil A; Mukherjee S; Das PK
    Int J Biochem Cell Biol; 2006; 38(8):1277-89. PubMed ID: 16507348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmania histone H1 overexpression delays parasite cell-cycle progression, parasite differentiation and reduces Leishmania infectivity in vivo.
    Smirlis D; Bisti SN; Xingi E; Konidou G; Thiakaki M; Soteriadou KP
    Mol Microbiol; 2006 Jun; 60(6):1457-73. PubMed ID: 16796681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-type immunoprotective response against experimental visceral leishmaniasis.
    Samant M; Gupta R; Kumari S; Misra P; Khare P; Kushawaha PK; Sahasrabuddhe AA; Dube A
    J Immunol; 2009 Jul; 183(1):470-9. PubMed ID: 19542458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening Leishmania donovani complex-specific genes required for visceral disease.
    Zhang WW; Matlashewski G
    Methods Mol Biol; 2015; 1201():339-61. PubMed ID: 25388124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the A2-A2rel gene cluster in Leishmania donovani: involvement of A2 in visceralization during infection.
    Zhang WW; Matlashewski G
    Mol Microbiol; 2001 Feb; 39(4):935-48. PubMed ID: 11251814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-cycle-dependent translation of histone mRNAs is the key control point for regulation of histone biosynthesis in Leishmania infantum.
    Soto M; Iborra S; Quijada L; Folgueira C; Alonso C; Requena JM
    Biochem J; 2004 May; 379(Pt 3):617-25. PubMed ID: 14766017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over-expression of Leishmania major MAP kinases reveals stage-specific induction of phosphotransferase activity.
    Morales MA; Renaud O; Faigle W; Shorte SL; Späth GF
    Int J Parasitol; 2007 Sep; 37(11):1187-99. PubMed ID: 17481635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leishmania donovani singly deficient in HGPRT, APRT or XPRT are viable in vitro and within mammalian macrophages.
    Boitz JM; Ullman B
    Mol Biochem Parasitol; 2006 Jul; 148(1):24-30. PubMed ID: 16597468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leishmania donovani: identification of novel vaccine candidates using human reactive sera and cell lines.
    Arora SK; Pal NS; Mujtaba S
    Exp Parasitol; 2005 Mar; 109(3):163-70. PubMed ID: 15713447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of a Leishmaniadonovani nucleotide sugar transporter in Leishmaniamajor enhances survival in visceral organs.
    Zhang WW; Chan KF; Song Z; Matlashewski G
    Exp Parasitol; 2011 Dec; 129(4):337-45. PubMed ID: 21978449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and localization of ORFF gene from the LD1 locus of Leishmania donovani.
    Jain M; Madhubala R
    Gene; 2008 Jun; 416(1-2):1-10. PubMed ID: 18423903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycoprotein 63 (gp63) genes show gene conversion and reveal the evolution of Old World Leishmania.
    Mauricio IL; Gaunt MW; Stothard JR; Miles MA
    Int J Parasitol; 2007 Apr; 37(5):565-76. PubMed ID: 17280675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-step generation of double-allele gene replacement mutants in Leishmania donovani.
    Ommen G; Lorenz S; Clos J
    Int J Parasitol; 2009 Apr; 39(5):541-6. PubMed ID: 19028498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crucial role of cytosolic tryparedoxin peroxidase in Leishmania donovani survival, drug response and virulence.
    Iyer JP; Kaprakkaden A; Choudhary ML; Shaha C
    Mol Microbiol; 2008 Apr; 68(2):372-91. PubMed ID: 18312262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A heterologous prime-boost vaccination regimen using ORFF DNA and recombinant ORFF protein confers protective immunity against experimental visceral leishmaniasis.
    Tewary P; Jain M; Sahani MH; Saxena S; Madhubala R
    J Infect Dis; 2005 Jun; 191(12):2130-7. PubMed ID: 15898000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced expression of lipophosphoglycan (LPG) and kinetoplastid membrane protein (KMP)-11 in Leishmania donovani promastigotes in axenic culture.
    Mukhopadhyay S; Sen P; Majumder HK; Roy S
    J Parasitol; 1998 Jun; 84(3):644-7. PubMed ID: 9645879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-protection against Leishmania donovani but not L. Braziliensis caused by vaccination with L. Major soluble promastigote exogenous antigens in BALB/c mice.
    Tonui WK; Titus RG
    Am J Trop Med Hyg; 2007 Mar; 76(3):579-84. PubMed ID: 17360887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.